Intel is in the forefront to use AI to deliver transformative healthcare solutions. NetraAI is cloud-based AI solution which uses deep learning to identify retinal conditions in a short span of time with the accuracy level of ophthalmologists. In India, we have a shortage of trained retinal specialists in remote and interior areas. It constrains the screening of asymptomatic patients. They come late with advanced diabetic eye disease.

A Singapore IT firm Leben developed NetraAI for Sankara Eye Foundation. It assesses retina risk comprehensively. It is offered as software-as-a-service platform. It analyses images from fundus camera devices for immediate results of referable DR grading via a cloud-based web portal.

It uses advanced algorithms with a four-step deep convolutional neural network. This helps in detecting DR stage and annotating lesions based on pixel density in the fundus images. This can be extended to other retinal conditions and glaucoma. It is powered by Intel. Xeon Scalable processors and built-in Intel Deep Learning (DL) Boost accurately detect DR.